193 related articles for article (PubMed ID: 23493157)
21. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
Xiang TX; Anderson BD
J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
[TBL] [Abstract][Full Text] [Related]
23. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems.
Hirasawa N; Ishise S; Miyata H; Danjo K
Drug Dev Ind Pharm; 2003 Oct; 29(9):997-1004. PubMed ID: 14606663
[TBL] [Abstract][Full Text] [Related]
24. Improved physical stability of amorphous state through acid base interactions.
Telang C; Mujumdar S; Mathew M
J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
[TBL] [Abstract][Full Text] [Related]
25. Effect of different carriers on in vitro dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions.
Qian J; Li F; Zhang C; Chai S; Liu T; Sui X
Pak J Pharm Sci; 2022 Nov; 35(6):1539-1548. PubMed ID: 36789813
[TBL] [Abstract][Full Text] [Related]
26. Physiochemical Characterization and Release Rate Studies of SolidDispersions of Ketoconazole with Pluronic F127 and PVP K-30.
Kumar P; Mohan C; Kanamsrinivasan Uma Shankar M; Gulati M
Iran J Pharm Res; 2011; 10(4):685-94. PubMed ID: 24250403
[TBL] [Abstract][Full Text] [Related]
27. The Opposed Effects of Polyvinylpyrrolidone K30 on Dissolution and Precipitation for Indomethacin Supersaturating Drug Delivery Systems.
Wang W; Li M; Yang Q; Liu Q; Ye M; Yang G
AAPS PharmSciTech; 2020 Mar; 21(3):107. PubMed ID: 32185564
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.
Zhai X; Li C; Lenon GB; Xue CCL; Li W
Asian J Pharm Sci; 2017 Jan; 12(1):85-97. PubMed ID: 32104317
[TBL] [Abstract][Full Text] [Related]
29. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
31. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
32. Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).
Damian F; Blaton N; Desseyn H; Clou K; Augustijns P; Naesens L; Balzarini J; Kinget R; Van den Mooter G
J Pharm Pharmacol; 2001 Aug; 53(8):1109-16. PubMed ID: 11518020
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
[TBL] [Abstract][Full Text] [Related]
34. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
35. Clarification of the Dissolution Mechanism of an Indomethacin/Saccharin/Polyvinylpyrrolidone Ternary Solid Dispersion by NMR Spectroscopy.
Kosaka M; Higashi K; Nishimura M; Ueda K; Moribe K
J Pharm Sci; 2020 Dec; 109(12):3617-3624. PubMed ID: 32931779
[TBL] [Abstract][Full Text] [Related]
36. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
Mallick S; Sahu A; Pal K
Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
[TBL] [Abstract][Full Text] [Related]
37. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
[TBL] [Abstract][Full Text] [Related]
38. Preparation of evodiamine solid dispersions and its pharmacokinetics.
Xu H; Zhang T; Yang H; Xiao X; Bian Y; Si D; Liu C
Indian J Pharm Sci; 2011 May; 73(3):276-81. PubMed ID: 22457550
[TBL] [Abstract][Full Text] [Related]
39. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
40. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
